BioNTech SE

$89.50
Market Cap 21.48B
ROE -6.7%
Gross Margin 39.5%
Debt/Equity 0.0
Current Ratio 8.8
Revenue QoQ -35.4%
EPS QoQ 0.2%
F-Score 3

About

BioNTech SE ADS

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-14.99
vs median 15.30
P/B
1.00
vs median 3.52
ROE
-0.07
vs median 0.21

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

INCYROIVINSMMRNAUTHRGMAB
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics